ELANCO ANIMAL HEALTH INC (ELAN:NYSE)
$23.06 -0.18 (-0.7745%)
Analysed ELANCO ANIMAL HEALTH INC (ELAN:NYSE) News Sources
APA Gears Up to Report Q3 Earnings: Here's How It Will Fare
29-10-2026
yahoo.com
4 Medical Stocks With a Healthy Shot at Q3 Earnings Beats
30-10-2026
yahoo.com
Luciana Amaro Joins Franklin Electric as Chief Human Resources Officer
19-10-2026
yahoo.com
2 Cash-Producing Stocks for Long-Term Investors and 1 Facing Headwinds
06-10-2026
yahoo.com
One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal Health
07-10-2026
yahoo.com
Q2 Earnings Outperformers: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Stocks
14-10-2026
yahoo.com
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
19-10-2026
yahoo.com
Does Elanco Animal Health (ELAN) Sit Below Fair Value After Zenrelia?
22-10-2026
yahoo.com
Elanco Animal Health Appoints Jamie Preston as Chief People Officer
22-10-2026
yahoo.com
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
30-10-2026
yahoo.com
What is the current price of ELANCO ANIMAL HEALTH INC (ELAN:NYSE)?
The current price of ELANCO ANIMAL HEALTH INC (ELAN:NYSE) is $23.06.
ELANCO ANIMAL HEALTH INC (ELAN:NYSE) absolute price change since previous trading day?
The absolute price change of ELANCO ANIMAL HEALTH INC (ELAN:NYSE) since the previous trading day is $-0.18.
ELANCO ANIMAL HEALTH INC (ELAN:NYSE) percentage price change since previous trading day?
The percentage price change of ELANCO ANIMAL HEALTH INC (ELAN:NYSE) since the previous trading day is -0.7745%.
What is the most recent average sentiment score for ELANCO ANIMAL HEALTH INC (ELAN:NYSE)?
The most recent average sentiment score for ELANCO ANIMAL HEALTH INC (ELAN:NYSE) is 80 out of 100.
What is the most recent average sentiment for ELANCO ANIMAL HEALTH INC (ELAN:NYSE)?
The most recent sentiment for ELANCO ANIMAL HEALTH INC (ELAN:NYSE) is .
SEC-8K** Filing Available For ELANCO ANIMAL HEALTH INC (ELAN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.